SEC Filing Summary: SIM Acquisition Corp. I (10-K)
Business Context and Reporting Period
Company: SIM Acquisition Corp. I (SIMA)
Reporting Period: Fiscal year ended December 31, 2024 (Inception: January 29, 2024)
Business Type: Special Purpose Acquisition Company (SPAC) incorporated in the Cayman Islands.
Objective: To effect a Business Combination with one or more target businesses, primarily focused on the healthcare industry.
Key Milestones:
- Initial Public Offering (IPO) consummated on July 11, 2024.
- Units (SIMAU), Class A Ordinary Shares (SIMA), and Warrants (SIMAW) began trading on Nasdaq in July and August 2024.
- Combination Period: 24 months from IPO closing (deadline: July 11, 2026).
Key Financial Metrics
| Metric | Value (as of Dec 31, 2024) |
|---|---|
| Trust Account Balance | $235,322,812 |
| Per Share Trust Value | ~$10.23 |
| Cash Outside Trust | $697,085 |
| Total Assets | $236,327,097 |
| Net Income (Inception to Dec 31, 2024) | $4,747,104 |
| Net Income (Q4 2024) | $2,436,140 |
| Operating Expenses (Inception to Dec 31, 2024) | $575,708 |
| Deferred Underwriting Commissions | $10,950,000 |
| Outstanding Class A Shares (Public) | 23,000,000 |
| Outstanding Class B Shares (Founder) | 7,666,667 |
Material Changes and Operational Status
Capital Structure: The company raised $230,000,000 in gross proceeds from the IPO of 23,000,000 Units at $10.00 per unit. Simultaneously, $6,000,000 was raised from the private placement of warrants. A total of $230,000,000 was deposited into the Trust Account.
Revenue Generation: The company has no operating revenue. Net income is derived entirely from interest earned on cash and marketable securities held in the Trust Account ($5,322,812 for the period from inception).
Liquidity: The company maintains approximately $697,085 in cash outside the Trust Account to fund working capital and transaction costs. Management believes this is sufficient for operations for at least one year.
Outlook, Risks, and Contingencies
Guidance: No specific financial guidance is provided as the company is pre-revenue and pre-transaction. The primary goal is to identify and consummate a Business Combination by July 11, 2026.
Key Risks:
- Combination Deadline: Failure to complete a Business Combination by July 11, 2026, will result in liquidation and redemption of Public Shares.
- Regulatory Environment: New SEC "2024 SPAC Rules" adopted in January 2024 may increase costs and time required to complete a transaction.
- Trust Account Claims: While the Sponsor has agreed to indemnify the Trust Account against certain third-party claims, there is no guarantee the Sponsor has sufficient assets to satisfy such obligations.
- Market Conditions: Geopolitical instability and economic volatility could impact the ability to find a suitable target or complete a transaction.
Contingencies:
- Extension: The company may seek shareholder approval to extend the Combination Period, which would require Public Shareholders to redeem shares or vote in favor.
- Working Capital Loans: The Sponsor or affiliates may loan up to $1,500,000 in working capital, convertible into warrants, to finance transaction costs.
Investor Verification Checklist
- Trust Account Balance: Verify the current per-share redemption value (approx. $10.23) against the $10.00 IPO price to assess interest accrual.
- Combination Timeline: Confirm the July 11, 2026, deadline and monitor for any announcements regarding extensions.
- Deferred Fees: Note the $10,950,000 deferred underwriting commission payable only upon successful completion of a Business Combination.
- Sponsor Indemnity: Review the Sponsor's ability to satisfy indemnification obligations if third-party claims reduce the Trust Account below $10.00 per share.
- Regulatory Compliance: Monitor the impact of the 2024 SPAC Rules on the company's ability to negotiate and close a deal.